Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Dopamine Receptor d1 Antikörper (AA 338-446)

DRD1 Reaktivität: Ratte WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN1867631
  • Target Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigen
    Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
    Bindungsspezifität
    • 16
    • 16
    • 14
    • 7
    • 7
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 338-446
    Reaktivität
    • 80
    • 67
    • 44
    • 9
    • 7
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Ratte
    Wirt
    • 86
    • 5
    • 1
    Kaninchen
    Klonalität
    • 78
    • 13
    Polyklonal
    Konjugat
    • 37
    • 8
    • 6
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Dieser Dopamine Receptor d1 Antikörper ist unkonjugiert
    Applikation
    • 69
    • 32
    • 27
    • 26
    • 26
    • 26
    • 17
    • 17
    • 16
    • 9
    • 8
    • 8
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
    Verwendungszweck
    Polyclonal Antibody to Dopamine Receptor D1 (DRD1)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against DRD1. It has been selected for its ability to recognize DRD1 in immunohistochemical staining and western blotting.
    Kreuzreaktivität
    Human, Maus
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant Dopamine Receptor D1 (DRD1) corresdonding to Gln338~Thr446 with N-terminal His Tag
    Isotyp
    IgG
    Top Product
    Discover our top product DRD1 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Handhabung
    Avoid repeated freeze/thaw cycles
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
    Andere Bezeichnung
    Dopamine Receptor D1 (DRD1 Produkte)
    Synonyme
    DRD1 antikoerper, Dop1 antikoerper, D1A antikoerper, DADR antikoerper, DRD1A antikoerper, drd1 antikoerper, C030036C15Rik antikoerper, Drd-1 antikoerper, Drd1 antikoerper, Gpcr15 antikoerper, D1a antikoerper, Drd1a antikoerper, dopamine receptor D1 antikoerper, dopamine receptor, D1 antikoerper, dopamine receptor D1b antikoerper, DRD1 antikoerper, Dop1 antikoerper, drd1b antikoerper, Drd1 antikoerper
    Hintergrund
    DR-D1, D1R, DADR, DRD1A
    Pathways
    cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Sie sind hier:
Kundenservice